Dr. D. Christopher Metzger, MD
Claim this profileWellmont Cardiology Services
Studies Peripheral Arterial Disease
Studies Peripheral Vascular Disease
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials D. Christopher Metzger, MD is currently running
Stent Graft Systems
for Abdominal Aortic Aneurysm
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
Recruiting1 award N/A5 criteria
Impella-Supported PCI
for Coronary Heart Disease
The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.
Recruiting1 award N/A5 criteria
More about D. Christopher Metzger, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments D. Christopher Metzger, MD has experience with
- Stent-based Therapies
- Non-stent Based Therapies
- FDA Approved EVAR AAA Graft Systems
- Alto Abdominal Stent Graft System
- Carotid Artery Stenting With Neuroguard IEP System
- Impella®-Supported PCI
Breakdown of trials D. Christopher Metzger, MD has run
Peripheral Arterial Disease
Peripheral Vascular Disease
Aortic Aneurysm
Abdominal Aortic Aneurysm
Carotid Stenosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does D. Christopher Metzger, MD specialize in?
D. Christopher Metzger, MD focuses on Peripheral Arterial Disease and Peripheral Vascular Disease. In particular, much of their work with Peripheral Arterial Disease has involved treating patients, or patients who are undergoing treatment.
Is D. Christopher Metzger, MD currently recruiting for clinical trials?
Yes, D. Christopher Metzger, MD is currently recruiting for 2 clinical trials in Kingsport Tennessee. If you're interested in participating, you should apply.
Are there any treatments that D. Christopher Metzger, MD has studied deeply?
Yes, D. Christopher Metzger, MD has studied treatments such as Stent-based therapies, Non-stent based therapies, FDA Approved EVAR AAA Graft Systems.
What is the best way to schedule an appointment with D. Christopher Metzger, MD?
Apply for one of the trials that D. Christopher Metzger, MD is conducting.
What is the office address of D. Christopher Metzger, MD?
The office of D. Christopher Metzger, MD is located at: Wellmont Cardiology Services, Kingsport, Tennessee 37660 United States. This is the address for their practice at the Wellmont Cardiology Services.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.